Oxytocin Explored for Pain Relief via Intranasal and IV Routes

Pain is a complex and debilitating condition affecting millions globally, often managed with conventional analgesics, including opioids, which carry substantial risks of addiction, tolerance, and severe side effects. The urgent need for novel, non-addictive pain management strategies remains a critical challenge in modern medicine. While oxytocin is widely recognized for its roles in social bonding, trust, and maternal behaviors, emerging preclinical and early clinical evidence suggests it may also possess significant analgesic properties. This Phase 2 study aims to rigorously evaluate the analgesic efficacy and safety of oxytocin delivered via both intranasal and intravenous routes for acute noxious heat pain, thereby addressing a crucial knowledge gap in its potential as a non-opioid therapeutic for pain.